No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
976 |
4. Check minimum number of eventsNone |
976 |
5. Include endpointsNone |
976 |
6. Filter based on genotype QC (FinnGen only) |
976 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[5-9]|Q7
- Name in latin
- Deformitates congenitae pedum
Similar endpoints
↥List of similar endpoints to
Congenital deformities of feet
based on the number of shared cases.
Similar with more cases:
- Congenital malformations and deformations of the musculoskeletal system
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 12688 | 5897 | 6770 |
| Only index persons | 10876 | 5130 | 5746 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.18 | 0.17 | 0.19 |
| Only index persons | 0.20 | 0.19 | 0.22 |
| Median age at first event (years) | |||
| Whole population | 10.23 | 12.31 | 8.35 |
| Only index persons | 12.68 | 14.50 | 11.06 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 976 | 606 | 370 |
| Unadjusted period prevalence (%) | 0.19 | 0.21 | 0.16 |
| Median age at first event (years) | 36.82 | 38.46 | 34.14 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 870
- Matched controls
- 8700
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q66.7
ICD-10 Finland
Pes cavus
3428.5
285.6
260
*
Q66.0
ICD-10 Finland
Talipes equinovarus
2797.3
215.9
200
*
Q66.5
ICD-10 Finland
Congenital pes planus
321.0
160.4
158
6
Q66.8
ICD-10 Finland
Other congenital deformities of feet
+∞
117.4
110
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
7.7
79.2
201
326
Q66.9
ICD-10 Finland
Congenital deformity of feet, unspecified
277.1
75.7
76
*
Q66.2
ICD-10 Finland
Metatarsus varus
+∞
72.9
69
*
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
28.0
67.6
93
37
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
6.3
49.0
140
257
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
7.8
48.8
118
171
Q66.4
ICD-10 Finland
Talipes calcaneovalgus
+∞
47.3
45
*
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
9.7
45.6
96
110
7545B
ICD-9 Finland
Certain congenital musculoskeletal deformities, Varus deformities of feet[TALIPES EQUINOVARUS CONGENITUS]
+∞
45.2
43
*
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
23.7
44.7
64
29
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
29.6
39.5
53
19
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
8.9
37.8
83
102
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
9.2
36.4
78
92
Q66.6
ICD-10 Finland
Other congenital valgus deformities of feet
361.0
35.2
35
*
NHG22
NOMESCO Finland
Fusion of subtalar joint
30.3
34.6
46
16
75400
ICD-8 Finland
Clubfoot (congenital), Pes equino-varus adductus
93.8
33.0
36
*
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
55.1
31.5
37
7
M21.5
ICD-10 Finland
Acquired clawhand, clubhand, clawfoot and clubfoot
165.8
30.9
32
*
TNH36
NOMESCO Finland
Custom molded cast of pes equinovarus
+∞
30.4
29
*
9341
FHL
Reduction and plaster or plaster exchange
+∞
30.4
29
*
M20.1
ICD-10 Finland
Hallux valgus (acquired)
4.6
30.1
110
263
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
13.8
29.5
51
39
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
7.1
28.7
72
109
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
7.6
28.1
67
94
NHL99
NOMESCO Finland
Other operation on muscle or tendon of ankle or foot
19.9
26.7
40
21
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
11.5
26.6
50
46
NH1AD
NOMESCO Finland
Ankle and foot CT
9.9
26.6
54
58
Q66.3
ICD-10 Finland
Other congenital varus deformities of feet
+∞
26.2
25
*
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
11.5
26.1
49
45
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
13.2
24.6
43
34
9343
FHL
Posterior release or posteromedical release
+∞
24.1
23
*
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
8.4
23.8
53
67
L17
ICPC
Foot/toe symptom/complaint
2.3
22.6
265
1399
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.9
22.5
99
280
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
22.0
317
1835
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.9
21.3
144
558
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.8
21.2
61
111
NHT62
NOMESCO Finland
Surgical procedure for correction of pes equinovarus
+∞
20.9
20
*
SPAT1229
SPAT
Assessment of need for aid
4.5
20.9
77
185
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
26.2
20.5
28
11
ZXA00
NOMESCO Finland
Right side
2.3
20.4
223
1127
B01AB05
ATC
enoxaparin; parenteral
2.3
20.4
227
1159
M79.6
ICD-10 Finland
Pain in limb
2.1
20.2
320
1911
M19.2
ICD-10 Finland
Other secondary arthrosis
11.7
20.1
37
33
L16
ICPC
Ankle symptom/complaint
2.8
20.1
144
578
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
4.3
19.4
74
184
WX320
NOMESCO Finland
Spinalanesthesy
2.4
19.1
184
873
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
18.5
237
1285
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
13.9
18.3
31
23
NHL20
NOMESCO Finland
Myotomy or tenotomy of foot
25.7
18.3
25
10
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
8.3
18.2
40
50
NH3EA
NOMESCO Finland
Feet X-ray examination with load
8.3
18.2
40
50
TQW40
NOMESCO Finland
Remowal of suture of skin
3.6
17.9
83
245
L84
ICD-10 Finland
Corns and callosities
6.0
17.8
49
85
ZXA05
NOMESCO Finland
Left side
2.2
17.5
197
1003
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
6.1
17.5
48
83
NH1FA
NOMESCO Finland
Weight-bearing X-ray of ankle
14.2
17.4
29
21
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
4.3
17.1
65
161
N02BE01
ATC
paracetamol; systemic, rectal
2.0
17.1
689
5670
Q66.1
ICD-10 Finland
Talipes calcaneovarus
173.1
16.5
17
*
N02AX02
ATC
tramadol; systemic, rectal
1.9
16.0
306
1923
G60.0
ICD-10 Finland
Hereditary motor and sensory neuropathy
34.1
15.8
20
6
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
15.6
360
2413
M77.4
ICD-10 Finland
Metatarsalgia
3.5
15.0
72
219
N03AX16
ATC
pregabalin; oral
2.2
14.9
180
940
NHG20
NOMESCO Finland
Fusion of talocrural joint
21.5
14.7
21
10
R4110
NOMESCO Finland
Physiotherapy
2.0
14.4
221
1271
-
ICD-10 Finland
NA
7.2
14.2
34
49
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.7
14.2
102
409
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
6.7
14.0
35
54
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
13.8
310
2038
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.7
13.8
100
403
M25.5
ICD-10 Finland
Pain in joint
1.9
13.7
252
1545
L82
ICPC
Congenital anomaly musculoskeletal
76.3
13.6
15
*
M21.6
ICD-10 Finland
Other acquired deformities of ankle and foot
26.2
13.4
18
7
TNH31
NOMESCO Finland
Prefabricated orthosis, ankle or foot
7.4
13.3
31
43
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.4
13.3
65
201
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
12.9
80
293
NHL30
NOMESCO Finland
Suture or reinsertion of tendon of foot
14.3
12.8
21
15
Z50.1
ICD-10 Finland
Other physical therapy
3.7
12.7
56
160
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
11.2
12.6
23
21
N03AX12
ATC
gabapentin; oral
2.3
12.5
119
554
Z31.5
ICD-10 Finland
Genetic counselling
3.1
12.1
68
231
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
5.9
11.7
32
56
S18
ICPC
Laceration/cut
1.7
11.7
309
2112
NH1AI
NOMESCO Finland
Cone beam CT of ankle
30.5
11.7
15
5
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
5.6
11.3
32
59
Z3226
NOMESCO Finland
Physiotherapist
2.0
11.0
161
900
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
5.5
10.8
31
58
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
10.7
107
508
TNH32
NOMESCO Finland
Custom moulded split, ankle or foot
13.1
10.7
18
14
NHT99
NOMESCO Finland
Other operation on ankle or foot
60.7
10.6
12
*
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
3.6
10.6
47
136
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
6.3
10.5
27
44
M20.5
ICD-10 Finland
Other deformities of toe(s) (acquired)
12.2
10.4
18
15
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.5
10.3
47
139
NHG82
NOMESCO Finland
Fusion of other tarsal joint
9.7
10.3
20
21
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
10.1
92
419
9111
FHL
Plastering under anesthesia
16.9
9.9
15
9
NGL66
NOMESCO Finland
Transposition of tendon of knee or lower leg
26.3
9.8
13
5
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
26.3
9.8
13
5
NGK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of knee or lower leg
20.3
9.8
14
7
NHM10
NOMESCO Finland
Fasciotomy of ankle or foot
13.6
9.7
16
12
NH3BG
NOMESCO Finland
MRI of foot
10.2
9.5
18
18
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
4.1
9.5
36
91
S83.0
ICD-10 Finland
Dislocation of patella
4.1
9.4
35
87
J01FF01
ATC
clindamycin; systemic
1.7
9.4
203
1289
7545A
ICD-9 Finland
Certain congenital musculoskeletal deformities, Varus deformities of feet[TALIPES VARUS CONGENITUS]
+∞
9.4
9
*
M01AH05
ATC
etoricoxib; oral
1.6
9.4
427
3314
L28
ICPC
Limited function/disability (L)
2.2
9.4
98
474
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
9.1
295
2101
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.6
9.1
64
254
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.1
9.0
111
579
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
9.0
84
388
NHK68
NOMESCO Finland
Shortening or lengthening osteotomy of ankle or foot
18.8
8.9
13
7
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
4.9
8.9
28
59
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.3
8.9
79
357
M01AC06
ATC
meloxicam; systemic, rectal
1.7
8.8
235
1586
M76.7
ICD-10 Finland
Peroneal tendinitis
8.7
8.8
18
21
NH2AA
NOMESCO Finland
Heel X-ray examination
10.8
8.8
16
15
AA1AD
NOMESCO Finland
CT of head and brain
1.9
8.7
138
791
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
8.6
293
2104
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.8
8.6
54
200
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
8.6
182
1148
WX213
NOMESCO Finland
Lower leg blockade
10.2
8.5
16
16
NFK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of femur
20.2
8.5
12
6
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.8
8.5
27
58
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
8.5
103
535
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
8.4
77
352
Q65.0
ICD-10 Finland
Congenital dislocation of hip, unilateral
+∞
8.3
8
*
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
5.6
8.3
23
42
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
8.3
235
1611
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.9
8.2
120
667
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
8.2
186
1198
ZXA10
NOMESCO Finland
Bilateral
1.9
8.1
132
763
9344
FHL
Other operation on soft tissue of the foot
33.7
8.1
10
*
M02AA07
ATC
piroxicam; topical
1.6
8.0
215
1448
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
6.4
8.0
20
32
NHG70
NOMESCO Finland
Arthroplasty of first tarsometatarsal joint
6.2
7.9
20
33
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
7.8
58
239
UJF32
NOMESCO Finland
Coloscopy
1.7
7.8
157
972
R4180
NOMESCO Finland
Podiatric therapy
7.0
7.8
18
26
NHH99
NOMESCO Finland
Other operation on joint of ankle or foot, unspecified
45.4
7.7
9
*
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.0
7.6
29
75
NH1CM
NOMESCO Finland
Ankle and foot extensive MRI examination with 3 Tesla magnet
25.2
7.6
10
*
M03BX02
ATC
tizanidine; oral
1.5
7.5
450
3641
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
7.5
65
291
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.5
7.4
55
226
9345
FHL
Tendon or tendon transplantation
80.7
7.4
8
*
NGU10
NOMESCO Finland
Removal of external fixation device from knee or lower leg
80.7
7.4
8
*
Z3231
NOMESCO Finland
Registered nurse
1.6
7.4
215
1477
NHU10
NOMESCO Finland
Removal of external fixation device from ankle or foot
8.5
7.3
15
18
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
7.3
194
1298
N06AX21
ATC
duloxetine; oral
2.0
7.3
88
454
M03BC01
ATC
orphenadrine (citrate); systemic
1.7
7.3
181
1191
Q65.1
ICD-10 Finland
Congenital dislocation of hip, bilateral
+∞
7.3
7
*
J01DB01
ATC
cefalexin; oral
1.6
7.2
670
5939
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.2
7.2
74
358
SPAT1210
SPAT
Application of cast or individual aid
2.9
7.2
42
151
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
7.1
154
972
L04AA01
ATC
[U] ciclosporin; systemic
5.4
7.1
20
38
A02BC01
ATC
omeprazole; systemic
1.7
7.1
174
1139
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
7.0
145
906
ZXE00
NOMESCO Finland
One hour or less
1.5
6.9
303
2284
M01AH01
ATC
celecoxib; oral (coxibs)
1.9
6.9
108
616
A02BC05
ATC
esomeprazole; systemic
1.5
6.9
258
1880
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
6.7
127
770
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
6.7
361
2834
R03AC02
ATC
salbutamol; inhalant
1.5
6.7
421
3415
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
6.7
106
607
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.3
6.6
23
55
SPAT1216
SPAT
Assessment of functional ability
2.0
6.6
87
465
M22.0
ICD-10 Finland
Recurrent dislocation of patella
4.8
6.6
20
42
J01AA02
ATC
doxycycline; systemic
1.5
6.6
534
4547
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.9
6.5
96
537
XKC03
NOMESCO Finland
Water cystometry
3.7
6.5
26
71
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
6.2
6.5
16
26
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
6.4
143
908
NH1BM
NOMESCO Finland
Ankle and foot MRI examination with 3 Tesla magnet
70.3
6.4
7
*
A03FA02
ATC
cisapride; oral, rectal
2.4
6.4
51
217
SPAT1301
SPAT
No procedures
1.5
6.4
243
1771
TNX39
NOMESCO Finland
Other orthopedic bandage, unspecified region
5.0
6.4
19
39
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
6.4
169
1128
M70.6
ICD-10 Finland
Trochanteric bursitis
2.0
6.3
73
372
G04BD07
ATC
tolterodine; oral
3.3
6.3
29
89
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
4.6
6.3
20
44
NK4EA
NOMESCO Finland
Joint X-ray examintion with load or wrench not elsewhere classified
11.1
6.3
11
10
R52.9
ICD-10 Finland
Pain, unspecified
2.1
6.3
68
337
M21.1
ICD-10 Finland
Varus deformity, not elsewhere classified
18.2
6.3
9
5
M21.0
ICD-10 Finland
Valgus deformity, not elsewhere classified
18.2
6.3
9
5
M66.4
ICD-10 Finland
Spontaneous rupture of other tendons
18.2
6.3
9
5
Q74.3
ICD-10 Finland
Arthrogryposis multiplex congenita
+∞
6.3
6
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
7.1
6.2
14
20
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
4.2
6.2
22
54
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
6.2
51
224
M67.0
ICD-10 Finland
Short Achilles tendon (acquired)
6.3
6.2
15
24
ZA7.0
ICD-10 Finland
Ankle and foot
5.8
6.2
16
28
J01DA01
ATC
[U] cefalexin; systemic
1.4
6.2
475
3979
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
3.3
6.2
29
91
H02AB04
ATC
methylprednisolone; systemic
1.8
6.2
95
541
M01AB05
ATC
diclofenac; systemic, rectal
1.4
6.0
456
3797
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.7
6.0
37
139
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40761535) Cells panel - Urine sediment
109
504
2.31
13.65
4.3
3.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
270
1723
1.78
13.61
4.3
3.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
379
2720
1.64
12.12
4.8
4.8
g/l
36.7
36.9
0.28
361
2543
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
135
721
2.01
11.67
7.3
5.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
105
517
2.16
11.26
2.4
2.3
ml/min/173m2
79.5
76.1
0.32
49
196
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
393
2899
1.60
10.94
6.0
6.1
mmol/l
1.2
1.2
1.12
368
2642
(3007853) Bacteria identified in Skin by Aerobe culture
154
886
1.88
10.66
2.2
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
165
973
1.84
10.55
2.3
2.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
247
1637
1.68
10.50
3.2
2.6
umol/l
1936.4
4652.9
0.82
225
1467
(3019150) Specific gravity of Urine by Refractometry
254
1704
1.66
10.28
4.2
3.3
kg/l
1.0
1.0
0.73
28
223
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
339
2444
1.59
10.24
4.3
3.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
112
586
2.03
10.22
21.8
15.3
inr
1.0
1.2
2.06
15
90
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
183
1130
1.76
10.01
3.2
2.7
e6/l
1.6
0.9
0.99
112
599
(3023368) Bacteria identified in Blood by Culture
235
1560
1.67
9.86
4.8
4.0
—
—
—
0
0
(3044889) 12 lead EKG panel
584
4784
1.55
9.84
3.6
3.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
512
4085
1.53
9.67
4.5
4.6
mmol/l
6.4
6.4
0.39
487
3731
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
417
3212
1.52
9.10
7.1
6.6
mmol/l
1.2
1.2
0.36
366
2737
(3018418) pH of Serum or Plasma
268
1871
1.60
9.08
3.9
3.5
ph
7.4
7.4
3.13
54
341
(3030467) Casts [#/volume] in Urine by Automated count
271
1900
1.59
9.01
3.9
2.9
e6/l
0.5
0.4
0.21
212
1385
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
264
1840
1.60
9.00
2.5
2.1
u/l
233.3
265.4
0.19
245
1740
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
446
3491
1.51
8.98
4.2
3.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
282
1999
1.58
8.93
5.1
3.4
estimate
0.0
0.0
1.28
85
732
(3006315) Basophils [#/volume] in Blood
496
3984
1.50
8.72
6.2
6.1
e9/l
0.0
0.0
1.02
445
3462
(3013115) Eosinophils [#/volume] in Blood
510
4122
1.50
8.69
6.3
6.5
e9/l
0.2
0.2
1.38
462
3648
(3001604) Monocytes [#/volume] in Blood
494
3973
1.49
8.58
6.3
6.1
e9/l
0.5
0.6
0.51
443
3453
(3000850) Epithelial cells [#/volume] in Urine
210
1402
1.63
8.48
3.0
2.5
e6/l
5.7
7.4
1.07
181
1236
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
877
8053
1.88
8.19
15.4
11.0
mg/l
20.6
20.9
0.11
724
6061
(36304419) Bacteria [Presence] in Urine
266
1896
1.55
8.11
3.4
2.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
274
1967
1.55
8.08
3.1
2.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
549
4544
1.48
8.05
8.9
8.8
e9/l
3.9
3.9
0.00
488
3956
(3013707) Erythrocyte sedimentation rate by Westergren method
650
5590
1.49
7.66
4.5
3.8
mm/h
9.7
9.7
0.05
623
5193
(3019198) Lymphocytes [#/volume] in Blood
505
4141
1.45
7.58
6.3
6.1
e9/l
2.0
2.0
0.15
458
3680
(3032080) INR in Blood by Coagulation assay
312
2331
1.50
7.55
6.8
6.4
inr
1.1
1.1
0.31
94
750
(3019550) Sodium [Moles/volume] in Serum or Plasma
848
7763
1.70
7.30
15.3
11.6
mmol/l
139.8
139.6
1.48
834
7553
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
292
2165
1.50
7.29
2.9
2.5
u/l
53.3
55.8
0.72
275
2004
(3035350) Ketones [Presence] in Urine by Test strip
470
3821
1.44
7.28
4.6
3.1
estimate
0.0
0.0
0.00
84
733
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
85
459
1.93
7.09
4.7
4.4
ng/l
74.8
70.8
0.12
78
418
(3009261) Glucose [Presence] in Urine by Test strip
474
3872
1.44
7.09
4.6
3.1
estimate
0.0
0.0
0.80
86
724
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
301
2260
1.48
7.01
3.3
3.0
ng/l
45.3
31.6
0.36
185
1236
(40758558) Short blood count panel - Blood
267
1960
1.50
6.94
7.0
6.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
195
1339
1.57
6.89
1.3
1.2
iu/ml
13.6
28.0
5.28
65
406
(3002582) Erythrocytes [#/volume] in Urine
281
2091
1.48
6.81
3.9
3.0
e6/l
20.5
99.3
1.55
222
1571
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
147
946
1.65
6.78
1.8
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
111
662
1.76
6.76
1.8
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
289
2168
1.47
6.71
3.0
3.0
mmol/l
2.3
2.4
1.86
270
1956
(3023103) Potassium [Moles/volume] in Serum or Plasma
847
7791
1.66
6.66
15.4
11.7
mmol/l
3.9
3.9
0.27
833
7554
(3019060) Gas panel - Arterial blood
64
321
2.06
6.57
4.2
5.8
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
104
614
1.78
6.55
6.0
8.2
kpa
5.0
5.2
1.06
99
589
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
192
1331
1.55
6.48
3.0
3.1
ng/l
764.5
820.7
0.12
159
1079
(3037522) Nuclear Ab [Titer] in Serum
166
1113
1.59
6.47
1.4
1.4
titre
451.7
517.3
0.17
24
208
(3021601) Nitrite [Presence] in Urine by Test strip
466
3836
1.41
6.46
5.9
4.3
estimate
0.0
0.0
0.50
87
752
(3003396) Base excess in Arterial blood by calculation
103
611
1.77
6.39
5.9
8.3
mmol/l
1.3
0.9
0.42
83
497
(3004588) Protein electrophoresis panel - Serum or Plasma
61
304
2.07
6.38
1.8
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
109
658
1.74
6.36
1.7
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
228
1654
1.49
6.20
2.1
1.9
mg/l
1.5
0.9
0.51
170
1212
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
433
3540
1.40
6.15
5.6
5.8
umol/l
10.3
10.8
0.42
409
3335
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
185
1293
1.53
5.99
1.3
1.2
u/ml
1.4
10.5
4.62
72
493
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
118
2.68
5.94
1.7
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
33
133
2.53
5.66
1.8
1.7
e6/l
8474.8
13376.7
0.45
24
95
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
368
2964
1.39
5.56
4.9
3.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
314
2475
1.40
5.35
1.8
1.7
pmol/l
97.9
96.4
0.20
161
1295
(3018095) Leukocytes [#/volume] in Urine
323
2570
1.38
5.17
4.4
3.4
e6/l
40.7
81.2
1.05
241
1700
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
378
3086
1.37
5.16
2.8
2.3
nmol/l
74.4
73.2
0.38
355
2838
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
621
5487
1.36
5.01
7.6
6.7
u/l
80.0
78.7
0.32
601
5163
(3003338) MCHC [Mass/volume]
799
7368
1.47
4.99
18.4
13.8
g/l
333.8
333.8
0.06
794
7321
(3020891) Body temperature
41
195
2.15
4.89
5.4
4.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
33
145
2.32
4.75
1.4
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
124
839
1.55
4.62
1.4
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
687
6226
1.35
4.33
4.3
3.8
pmol/l
14.6
14.5
0.54
641
5723
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
56
312
1.84
4.32
5.9
10.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
146
1043
1.47
4.20
2.0
2.6
mmol/l
2.4
2.4
0.96
133
910
(3024263) Appearance of Synovial fluid
11
27
4.11
4.17
1.8
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
137
978
1.47
3.96
2.3
2.4
s
30.1
29.6
0.50
132
951
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
100
2.44
3.91
1.3
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
890
8480
1.56
3.83
13.4
10.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
240
1899
1.35
3.82
4.8
4.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
588
5258
1.30
3.80
4.9
3.8
—
—
—
0
0
(44813793)
18
66
2.76
3.77
1.1
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
156
1153
1.42
3.74
2.8
3.2
ng/l
313.8
705.1
1.12
103
726
(3009508) Creatinine [Moles/volume] in Urine
259
2081
1.33
3.70
4.4
3.2
mmol/l
8.3
8.3
0.02
237
1795
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
81
526
1.59
3.63
2.4
3.3
pmol/l
4.7
4.7
0.14
76
469
(3022948) Iron [Moles/volume] in Serum or Plasma
137
996
1.44
3.60
3.0
2.3
umol/l
13.8
14.5
0.54
130
918
(3021960) Folate [Moles/volume] in Serum or Plasma
179
1369
1.38
3.51
1.5
1.4
nmol/l
21.1
20.6
0.15
170
1178
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
166
1255
1.39
3.49
1.5
1.6
pmol/l
449.3
28874969.7
1.52
150
1084
(4010399)
74
478
1.59
3.41
1.3
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
64
399
1.65
3.39
2.2
2.4
ug/l
13.0
7.7
0.37
58
361
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
706
6511
1.30
3.39
5.5
4.6
mmol/mol
38.3
38.4
0.13
674
6153
(3012516) Albumin [Mass/volume] in Urine
204
1605
1.34
3.34
3.4
3.3
mg/l
623.7
272.3
0.40
136
1067
(3020682) Albumin/Creatinine [Ratio] in Urine
211
1678
1.33
3.20
4.0
4.1
mg/mmol
7.6
10.7
0.56
148
1092
(3044640) Blood type and Crossmatch panel - Blood
275
2272
1.29
3.16
2.3
2.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
144
1083
1.39
3.13
3.5
2.8
e6/l
3.5
2.8
0.35
78
557
(3002385) Erythrocyte distribution width [Ratio]
759
7095
1.31
3.13
16.6
13.6
%
13.4
13.4
0.56
751
6966
(3022096) Basophils/100 leukocytes in Blood
418
3642
1.26
3.09
6.1
6.3
%
0.7
0.7
0.10
398
3430
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
8
7.54
3.06
4.8
8.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
52
317
1.68
3.03
2.3
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
434
3805
1.25
3.02
6.3
6.4
%
8.2
8.3
0.40
412
3601
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
777
7298
1.32
3.01
5.1
4.5
mu/l
1.8
2.1
0.76
746
6817
(3017446) Testosterone [Moles/volume] in Serum or Plasma
86
594
1.49
2.96
3.2
2.2
nmol/l
10.9
13.0
1.79
73
545
(3007461) Platelets [#/volume] in Blood
943
9176
1.82
2.95
21.7
16.0
e9/l
257.3
258.1
0.14
929
8960
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
761
7134
1.30
2.95
4.2
3.6
mmol/l
5.8
5.7
0.29
729
6631
(3002030) Lymphocytes/100 leukocytes in Blood
449
3961
1.25
2.93
6.0
6.2
%
29.4
30.0
0.56
425
3750
(3005322) IgE [Units/volume] in Serum or Plasma
88
613
1.48
2.91
1.5
1.3
u/ml
214.9
225.2
0.04
80
569
(3026782) Osmolality of Urine
170
1328
1.34
2.90
3.7
2.5
mosm/kgh2o
557.7
570.0
0.24
150
1150
(3006504) Eosinophils/100 leukocytes in Blood
430
3779
1.25
2.90
6.1
6.2
%
2.9
2.8
0.27
409
3550
(40760888) Immunoglobulin light chains.free panel - Serum
20
89
2.27
2.88
2.2
4.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
114
836
1.41
2.87
3.2
2.3
%
22.7
24.4
0.65
96
732
(3035941) MCH [Entitic mass]
943
9184
1.79
2.82
21.6
15.9
pg
30.1
30.0
0.22
938
9089
(3024731) MCV [Entitic volume]
943
9184
1.79
2.82
21.6
15.9
fl
89.9
89.8
0.30
938
9090
(3004789) Transferrin [Mass/volume] in Serum or Plasma
123
917
1.39
2.82
3.0
2.2
g/l
2.4
2.4
0.26
115
846
(3026361) Erythrocytes [#/volume] in Blood
943
9185
1.79
2.81
21.7
16.0
e12/l
4.6
4.6
0.15
927
8955
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
55
348
1.62
2.79
1.4
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
24
117
2.08
2.79
2.3
3.5
ratio
1.2
2.5
—
6
12
(3019309) Folate [Moles/volume] in Red Blood Cells
127
954
1.38
2.79
1.5
1.6
nmol/l
1340.5
1175.6
0.97
96
733
(3009214) Lutropin [Units/volume] in Serum or Plasma
58
373
1.59
2.76
1.6
1.6
u/l
9.0
8.2
0.15
46
296
(3010813) Leukocytes [#/volume] in Blood
943
9189
1.78
2.74
21.7
16.0
e9/l
6.8
6.6
0.95
929
8954
(3018010) Neutrophils/100 leukocytes in Blood
442
3916
1.24
2.71
6.1
6.0
%
56.3
55.7
0.54
421
3710
(3000963) Hemoglobin [Mass/volume] in Blood
943
9191
1.77
2.71
21.8
16.1
g/l
137.2
136.9
0.27
938
9093
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
11
37
3.00
2.70
1.3
1.5
%
36.8
34.7
—
6
26
(3014576) Chloride [Moles/volume] in Serum or Plasma
100
727
1.42
2.66
6.9
6.9
mmol/l
104.9
104.2
0.74
100
710
(3021589) Normoblasts [#/volume] in Blood
410
3609
1.23
2.66
9.8
8.5
e9/l
0.0
0.0
0.29
347
2916
(3043409) Potassium [Moles/volume] in Arterial blood
29
157
1.87
2.54
5.3
3.7
mmol/l
3.8
3.8
0.06
29
144
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
41
248
1.68
2.50
1.6
2.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
35
203
1.75
2.47
2.6
3.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
215
1772
1.27
2.47
2.4
2.2
mg/l
2.9
2.8
0.20
185
1522
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
21
3.83
2.46
4.5
6.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
27
3.35
2.39
1.0
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
97
2.08
2.38
1.5
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
49
315
1.58
2.37
1.5
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
43
268
1.63
2.36
4.7
6.3
kpa
9.7
9.2
1.09
43
248
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
28
3.23
2.31
5.3
2.1
ug/l
160.2
109.9
—
9
28
(3035637) Corticotropin [Mass/volume] in Plasma
20
99
2.04
2.27
1.6
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
22
113
1.97
2.26
3.6
2.4
%
17.0
16.4
0.34
13
54
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
875
8439
1.36
2.23
10.7
8.7
u/l
28.0
27.2
0.45
856
8175
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
349
0.51
2.22
1.9
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
21
107
1.98
2.21
1.1
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
68
478
1.45
2.20
3.7
5.3
mmol/l
1.4
1.4
0.00
47
346
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
86
632
1.40
2.18
2.9
2.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
86
632
1.40
2.18
2.6
2.8
g/l
11.4
10.2
1.44
80
574
(3021901) Oxygen saturation in Capillary blood
20
101
2.00
2.16
3.3
3.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
25
434
0.56
2.15
1.7
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
63
439
1.47
2.14
1.9
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
25
433
0.57
2.13
1.7
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
59
406
1.48
2.13
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
81
592
1.40
2.13
7.4
8.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
25
432
0.57
2.12
1.7
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
343
0.52
2.12
1.8
1.4
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
10
37
2.72
2.10
2.3
1.5
—
25.1
—
0
6
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
25
431
0.57
2.10
1.7
1.4
—
—
—
0
0
(3036489) Thrombin time
47
309
1.55
2.09
2.3
3.3
s
20.6
21.5
0.96
38
278
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
25
3.22
2.09
1.5
1.4
ug/l
11.6
7.9
—
8
25
(3009343) pH of Capillary blood
69
492
1.43
2.08
3.7
5.3
ph
7.4
7.4
—
10
44
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
108
831
1.34
2.07
2.9
3.3
umol/l
4.6
7.2
3.04
92
701
(3005033) Fetal Nuchal fold Thickness US
18
340
0.52
2.06
1.8
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
32
192
1.69
2.05
1.3
1.5
ug/g
256.5
303.6
0.61
17
115
(3022689) Creatine [Moles/volume] in Urine
6
15
4.02
2.04
1.5
1.3
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
11
4.56
1.94
4.6
5.6
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
5
11
4.56
1.94
4.4
5.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
45
2.46
1.93
5.0
2.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
301
2637
1.20
1.93
5.9
6.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
10
39
2.58
1.92
1.3
2.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
61
433
1.44
1.90
4.9
6.3
mmol/l
24.1
24.0
0.18
53
409
(3013139) Helicobacter pylori Ag [Presence] in Stool
67
484
1.41
1.90
1.2
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
74
544
1.39
1.90
6.5
7.8
mmol/l
1.3
1.3
0.09
68
521
(1761868) Lipid panel - Serum or Plasma
261
2987
0.83
1.87
2.2
2.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
45
302
1.51
1.86
7.8
9.8
mmol/l
23.9
24.3
0.29
39
288
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
301
2648
1.20
1.83
3.5
3.3
u/l
29.5
31.5
0.63
288
2523
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
38
247
1.56
1.81
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
17
87
1.97
1.80
1.7
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
8
29
2.77
1.79
1.5
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
746
7106
1.21
1.78
3.8
3.3
mmol/l
1.3
1.3
0.48
719
6691
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
45
305
1.50
1.78
2.2
2.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
65
475
1.39
1.75
4.7
3.4
mmol/l
1.2
1.2
1.81
60
409
(3014765) Yersinia sp identified in Stool by Organism specific culture
38
250
1.54
1.73
1.2
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
777
7438
1.22
1.73
4.3
3.7
mmol/l
4.6
4.7
1.18
749
7043
(3014051) Protein [Presence] in Urine by Test strip
27
163
1.68
1.73
3.0
1.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
31
479
0.64
1.72
1.7
1.5
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
13
3.86
1.71
2.8
6.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
13
3.86
1.71
4.2
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
37
243
1.54
1.70
1.8
1.6
—
215.0
—
0
8
(3025941) Bacteria identified in Stool by Culture
65
478
1.39
1.69
1.5
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
172
1.65
1.68
1.5
1.8
g/l
3.2
3.1
0.15
20
143
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
783
7509
1.22
1.66
4.7
4.0
mmol/l
2.8
2.8
0.35
752
7056
(3001122) Ferritin [Mass/volume] in Serum or Plasma
420
3827
1.17
1.66
3.2
2.8
ug/l
88.7
95.6
0.26
401
3579
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
19
3.17
1.66
4.7
3.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
160
1336
1.24
1.64
3.7
3.9
ug/l
2.8
1.9
0.30
149
1221
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
53
378
1.43
1.64
1.8
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
21
120
1.77
1.63
1.5
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
96
755
1.30
1.62
2.5
2.0
nmol/l
333.1
370.3
1.12
89
699
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
182
1.61
1.62
1.5
1.8
g/l
7.8
7.4
0.47
22
148
(3022621) pH of Urine by Test strip
61
448
1.39
1.61
2.5
2.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
64
851
0.73
1.61
1.6
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
595
5581
1.17
1.61
3.1
3.0
u/l
40.6
39.3
0.20
566
5310
(42529406) Shigella sp [Presence] in Stool by Culture
38
255
1.51
1.60
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
267
2350
1.19
1.60
1.8
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
144
1.68
1.58
5.0
4.7
u/ml
0.3
0.4
0.53
13
82
(3027315) Oxygen [Partial pressure] in Blood
23
137
1.70
1.56
6.1
2.7
kpa
8.9
9.0
0.12
23
137
(3030981) Hyaline casts [#/volume] in Urine by Automated count
46
323
1.45
1.56
4.5
2.5
e6/l
0.2
0.1
0.50
40
310
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
46
323
1.45
1.56
1.5
2.1
u/l
41.4
39.0
0.33
40
294
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
201
1728
1.21
1.55
2.4
2.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
12
57
2.12
1.55
1.3
1.3
nmol/l
1.4
1.3
0.18
12
51
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
79
609
1.32
1.54
3.2
2.4
u/l
8584.3
3310.3
0.71
28
255
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
15
3.34
1.52
1.2
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
16
86
1.87
1.51
1.3
1.3
pmol/l
853.3
341.0
1.39
11
66
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
21
2.87
1.50
1.2
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
129
1064
1.24
1.49
3.3
3.6
%
24.9
21.0
1.55
49
409
(3032773) Endomysium IgG Ab [Titer] in Serum
5
129
0.38
1.49
1.0
1.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
29
187
1.57
1.47
1.7
2.0
e6/l
129.8
179.1
0.18
24
144
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
29
187
1.57
1.47
1.7
1.9
e6/l
3.0
10.2
0.90
22
140
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
80
1.89
1.45
1.0
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
260
2303
1.18
1.43
1.3
1.4
u/ml
0.7
1.8
2.90
79
582
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
170
1976
0.83
1.41
1.7
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
39
548
0.70
1.39
1.5
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
83
655
1.29
1.39
4.7
5.4
mmol/l
1.8
1.7
0.09
68
518
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
182
1.55
1.38
1.5
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
182
1.55
1.38
1.5
1.8
g/l
4.5
3.8
1.34
20
139
(3023520) Reticulocytes [#/volume] in Blood
59
446
1.34
1.34
2.6
3.4
e9/l
83.1
72.6
0.56
49
326
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
105
1.73
1.33
1.1
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
68
526
1.31
1.32
1.6
1.5
iu/l
18.7
22.7
0.54
59
429
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
206
0.53
1.30
1.5
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
24
2.51
1.30
3.2
5.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
9
43
2.10
1.30
1.7
3.2
umol/l
29.7
28.9
—
9
43
(3013290) Carbon dioxide [Partial pressure] in Blood
22
137
1.62
1.30
6.2
2.7
kpa
5.3
4.9
2.04
22
137
(3012501) Base excess in Blood by calculation
22
137
1.62
1.30
6.2
2.7
mmol/l
2.2
2.5
0.24
17
82
(3002256) Pathology report gross observation
104
853
1.25
1.28
1.2
1.2
—
—
—
0
0
(4062490)
15
84
1.80
1.27
1.8
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
16
92
1.75
1.25
1.8
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
81
649
1.27
1.23
2.4
3.9
%
2.1
1.7
0.60
73
590
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
225
0.57
1.20
1.5
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
44
324
1.37
1.20
1.4
1.8
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
12
64
1.89
1.18
1.5
1.4
u/ml
0.3
0.3
—
5
25
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
133
1.59
1.18
1.3
1.2
u/ml
2.0
3.6
—
6
44
(40768804) Tissue Pathology biopsy report
311
2833
1.14
1.16
1.9
2.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
26
174
1.51
1.16
1.7
2.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
5
20
2.51
1.15
3.6
2.0
nmol/l
4.9
5.5
—
5
20
(3019832) Treponema pallidum Ab [Presence] in Serum
134
1560
0.84
1.14
2.0
1.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
30
2.34
1.12
1.7
1.9
—
—
—
0
0
(4268621)
15
88
1.72
1.11
2.6
2.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
26
176
1.49
1.11
2.1
1.6
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
13
73
1.79
1.11
1.0
1.1
u/ml
0.2
2.9
—
7
34
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
96
1.68
1.10
1.3
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
84
687
1.24
1.09
2.5
2.5
u/l
25.8
32.9
1.75
70
578
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
110
931
1.20
1.04
1.7
1.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
36
264
1.38
1.03
4.3
4.2
g/l
0.4
0.3
0.39
18
132
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
31
223
1.40
0.99
2.5
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
62
766
0.80
0.97
4.5
3.6
%
32.0
31.9
0.02
54
546
(3000034) Microalbumin [Mass/volume] in Urine
10
54
1.86
0.97
5.1
2.9
mg/l
19.0
16.3
—
10
37
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
86
717
1.22
0.96
1.3
1.2
iu/ml
73.9
159.3
2.25
36
286
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
158
1.47
0.94
1.4
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
77
924
0.82
0.92
1.5
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
52
1.74
0.92
2.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
78
1.68
0.92
1.2
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
49
386
1.28
0.90
4.0
5.7
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
6
29
2.08
0.89
9.7
6.6
g/mol
40.2
84.6
—
6
24
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
29
2.08
0.89
1.7
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
762
7402
1.13
0.89
4.2
3.6
mmol/l
1.4
1.5
1.35
736
6983
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
14
87
1.62
0.88
1.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
144
1.47
0.87
1.0
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
144
1.47
0.87
1.0
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
73
605
1.22
0.87
1.1
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
30
2.01
0.87
2.2
1.1
%
80.2
95.6
—
6
30
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
30
2.01
0.87
2.0
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
56
451
1.26
0.87
1.0
1.1
—
0.9
—
0
5
(3051611) Lipemic interference index of Serum or Plasma
11
64
1.73
0.86
3.1
4.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
62
506
1.24
0.86
1.2
1.3
au/ml
64.0
37.7
—
5
24
(3049717) Cytology report of Urine Cyto stain
23
162
1.43
0.85
2.0
2.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
206
1869
1.13
0.82
1.8
1.7
mmol/l
1.4
1.4
0.07
180
1624
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
32
1.88
0.82
1.7
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
6
32
1.88
0.82
3.2
2.0
mmol/l
10.2
8.9
—
6
25
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
13
81
1.61
0.81
1.1
1.2
—
296.0
—
0
5
(3021879) Hepatitis B virus core Ab [Presence] in Serum
71
846
0.83
0.81
1.4
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
19
130
1.47
0.81
1.5
2.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
176
1583
1.14
0.80
1.6
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
39
304
1.29
0.79
5.8
2.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
734
7132
1.12
0.79
12.0
9.5
ml/min/173m2
92.9
92.3
0.29
599
5653
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
33
1.82
0.79
1.2
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
19
131
1.46
0.78
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
97
0.51
0.78
2.4
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
82
1.59
0.78
1.2
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
98
0.51
0.78
2.4
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
22
157
1.41
0.77
1.2
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
34
1.77
0.76
2.3
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
19
132
1.45
0.76
1.4
1.2
u/ml
3.8
5.9
0.49
12
58
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
75
1.61
0.75
1.0
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
20
141
1.43
0.75
1.7
1.9
g/l
0.0
0.0
0.50
20
135
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
24
2.09
0.74
2.4
2.8
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
48
388
1.25
0.74
1.3
1.7
mg/l
4.2
3.3
0.37
32
263
(3003888) Timothy IgE Ab [Units/volume] in Serum
34
264
1.30
0.72
1.0
1.1
u/ml
8.6
6.9
0.21
17
164
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
23
168
1.38
0.72
1.3
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
22
160
1.38
0.70
1.4
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
41
1.71
0.70
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
72
613
1.19
0.69
1.3
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
42
1.67
0.68
1.1
1.7
—
—
—
0
0
(4034850)
29
223
1.31
0.67
7.2
7.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
43
1.63
0.67
1.0
1.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
28
1.79
0.66
1.0
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
70
1.58
0.65
2.1
2.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
25
189
1.33
0.65
1.2
1.9
mmol/l
3.6
3.7
0.04
25
177
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
17
120
1.42
0.65
1.2
1.5
mmol/l
6.5
6.9
0.48
11
80
(3009542) Hematocrit [Volume Fraction] of Blood
807
7910
1.12
0.64
14.1
11.8
%
40.4
40.6
0.24
632
6420
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
216
1.31
0.64
1.8
1.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
65
760
0.84
0.64
4.9
1.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
19
138
1.38
0.63
7.6
2.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.2
2.0
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
41
335
1.23
0.60
3.4
4.5
g/l
128.2
129.8
0.18
41
329
(3051651) Icteric interference index of Serum or Plasma
8
51
1.57
0.60
3.6
4.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
32
254
1.27
0.60
1.0
1.1
u/ml
0.4
1.3
1.04
14
129
(3016018) Differential panel - Cerebral spinal fluid
12
80
1.51
0.60
2.4
2.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
114
1.41
0.59
1.3
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
61
711
0.85
0.59
5.0
2.0
—
—
—
0
0
(4146454)
8
53
1.51
0.58
2.1
3.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
65
753
0.85
0.58
4.8
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
114
0.61
0.58
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
66
763
0.86
0.58
4.8
1.9
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
18
132
1.37
0.57
1.8
1.9
g/l
0.0
0.0
0.00
18
127
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
36
1.67
0.56
1.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
73
1.51
0.56
1.4
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
65
1.54
0.55
2.5
3.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
18
133
1.36
0.55
1.8
1.9
g/l
0.0
0.0
0.00
18
127
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
56
653
0.85
0.55
1.2
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
12
82
1.47
0.54
1.5
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
38
1.58
0.54
1.2
1.3
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
6
38
1.58
0.54
1.2
1.2
%
109.5
112.6
—
6
31
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
61
1.48
0.53
3.0
2.1
pg
33.0
32.6
—
9
61
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
6
39
1.54
0.53
1.2
1.2
g/l
0.3
0.3
—
6
33
(3000093) Morphology [Interpretation] in Blood Narrative
10
66
1.52
0.52
1.1
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
63
1.43
0.52
1.2
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
63
1.43
0.52
1.4
2.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
96
0.62
0.52
2.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
98
0.61
0.52
2.2
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
66
755
0.87
0.52
4.8
2.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
217
2030
1.09
0.50
1.3
1.5
g/l
2.0
2.2
0.60
144
1222
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
67
1.50
0.49
2.5
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
85
758
1.13
0.49
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
37
308
1.21
0.48
1.6
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
93
1.40
0.48
1.0
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
119
1.35
0.48
1.1
1.9
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
14
102
1.38
0.47
1.1
1.1
g/l
1.4
1.4
0.18
14
90
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
236
1.24
0.47
2.0
2.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
65
571
1.15
0.47
4.4
4.6
%
1.1
1.0
0.09
23
156
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
17
129
1.32
0.46
3.1
2.7
nmol/l
28.5
23.6
0.73
17
124
(3048689) Calprotectin [Mass/mass] in Stool
136
1252
1.10
0.45
2.1
2.5
ug/g
101.1
108.7
0.17
114
980
(3014599) Egg white IgE Ab [Units/volume] in Serum
12
86
1.40
0.44
1.1
1.1
u/ml
6.8
2.6
—
5
36
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
16
208
0.77
0.44
1.4
1.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
7
51
1.38
0.44
1.4
1.5
ug/l
4.0
6.4
—
7
43
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
33
275
1.21
0.44
1.7
1.3
—
—
—
0
0
(44790047)
13
95
1.37
0.44
1.5
1.6
—
—
—
0
0
(44806118)
13
95
1.37
0.44
1.5
1.6
—
—
—
0
0
(44790048)
13
95
1.37
0.44
1.5
1.6
—
—
—
0
0
(44790049)
13
95
1.37
0.44
1.5
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
40
340
1.18
0.43
1.4
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.2
1.9
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
31
1.62
0.43
2.2
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
31
1.62
0.43
2.2
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
92
0.65
0.42
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
131
1.30
0.42
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
95
0.63
0.42
2.2
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
95
0.63
0.42
2.2
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
20
158
1.27
0.42
1.6
1.4
u/l
21.8
18.9
0.16
14
139
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
70
1.43
0.41
1.1
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
52
593
0.87
0.41
5.7
2.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
33
277
1.20
0.41
1.3
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
3.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
12
161
0.74
0.41
2.6
3.6
mg/l
21.0
25.1
—
7
104
(3035320) C reactive protein [Mass/volume] in Body fluid
8
59
1.36
0.41
2.1
2.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
54
474
1.15
0.41
1.6
1.5
mu/l
275.4
296.3
0.45
47
425
(4198724)
11
79
1.40
0.41
2.6
2.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.1
—
0.7
—
0
10
(4306422)
16
123
1.31
0.40
1.3
1.2
—
—
—
0
0
(4211845)
5
34
1.47
0.40
2.6
2.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
88
1.37
0.40
1.0
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
103
0.68
0.39
1.4
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.2
1.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
71
1.41
0.39
1.1
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
169
1.25
0.39
1.3
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
98
1.33
0.37
1.2
1.7
—
—
—
0
0
(3013512) EKG study
176
1658
1.08
0.36
3.9
3.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
162
1.24
0.35
1.8
2.7
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
5
80
0.62
0.35
2.4
2.8
—
42.2
—
0
9
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
117
1.29
0.35
8.2
2.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
27
227
1.19
0.35
1.2
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
145
0.76
0.35
2.2
1.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
17
211
0.80
0.34
1.7
1.5
u/ml
98.8
98.3
—
5
37
(3023419) Bacteria identified in Sputum by Culture
10
73
1.37
0.34
2.0
4.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
18
145
1.25
0.34
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
32
371
0.86
0.33
1.3
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
6
46
1.31
0.33
1.5
1.5
mmol/l
5.2
5.9
—
6
46
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
88
0.68
0.33
1.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
90
0.66
0.33
1.3
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
110
1.28
0.32
1.9
1.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
101
1.29
0.32
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
262
0.84
0.31
1.2
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
52
1.35
0.31
5.3
2.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
54
486
1.12
0.30
2.7
4.3
ug/l
3.6
16.2
0.78
40
390
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
268
1.16
0.30
1.4
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
54
1.30
0.30
1.4
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
54
1.30
0.30
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
56
1.25
0.29
2.6
3.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
51
460
1.11
0.28
1.7
1.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
63
1.27
0.27
1.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
139
0.79
0.27
11.2
3.8
—
—
—
0
0
(4027681)
8
66
1.21
0.26
1.1
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
25
289
0.86
0.26
1.6
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
14
171
0.82
0.26
1.0
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
33
291
1.14
0.26
1.1
1.2
u/ml
4.3
2.6
0.26
13
135
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
73
0.68
0.26
1.4
1.8
—
—
—
0
0
(3000492) Spirometry study
87
811
1.08
0.26
1.3
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
74
1.22
0.25
1.1
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
9
75
1.20
0.25
6.6
8.7
mmol/l
6.2
6.8
—
9
59
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
255
0.86
0.24
1.2
1.4
u/ml
290.2
231.0
0.45
13
138
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
76
1.19
0.24
1.4
1.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
96
1.25
0.24
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
131
1243
1.06
0.24
1.9
1.7
%
1.4
1.4
0.16
124
1122
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
683
6741
1.04
0.24
3.9
3.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
30
265
1.14
0.24
1.2
1.6
iu/ml
0.1
0.0
—
8
45
(3041096) Erythrocytes [Presence] in Urine by Automated
215
2231
0.95
0.23
4.3
2.7
—
—
—
0
0
(3019225) pH of Specimen
51
557
0.91
0.23
6.1
3.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
59
544
1.09
0.23
4.6
4.6
%
0.1
0.1
0.41
18
143
(3003181) Sodium [Moles/volume] in Urine
7
93
0.75
0.22
1.1
1.5
mmol/l
52.9
78.2
—
7
83
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
88
827
1.07
0.22
1.1
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
18
210
0.85
0.22
1.2
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
98
925
1.07
0.22
1.3
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
1.7
—
0
11
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
18.9
—
0
10
(3011288) Drugs identified in Urine by Screen method
47
512
0.91
0.21
6.2
2.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
50
543
0.92
0.21
1.5
1.6
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.3
—
93.5
—
0
12
(3013293) Extractable nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
2.0
—
0
7
(3048879) Bone marrow aspiration report
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
37
408
0.90
0.21
1.6
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
43
1.16
0.21
1.0
3.0
u/ml
996.0
727.9
—
5
43
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
43
1.16
0.21
1.2
1.4
—
53.3
—
0
6
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.1
—
1.3
—
0
14
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
108
1.21
0.20
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
50
1.20
0.19
1.5
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
165
0.85
0.19
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
53
1.13
0.18
1.3
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
53
1.13
0.18
1.0
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
265
2581
1.04
0.18
1.6
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
59
1.19
0.18
1.4
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
59
1.19
0.18
1.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
59
1.19
0.18
1.4
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
59
1.19
0.18
1.4
1.7
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
59
1.19
0.18
1.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
153
0.85
0.18
1.5
1.3
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
17
195
0.87
0.17
1.3
1.3
ug/l
4.2
3.4
0.46
17
182
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
226
0.88
0.17
1.7
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
288
0.90
0.17
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
68
1.18
0.16
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
68
1.18
0.16
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
68
1.18
0.16
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
68
1.18
0.16
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
68
1.18
0.16
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
69
1.16
0.16
1.3
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
75
790
0.95
0.16
2.8
2.6
ug/l
0.5
0.7
1.07
42
440
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
79
1.14
0.15
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
89
931
0.95
0.15
2.3
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
81
1.11
0.15
1.0
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
82
1.10
0.15
1.4
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
243
2487
0.97
0.14
2.0
2.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
150
1.14
0.14
1.2
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
84
1.19
0.14
2.0
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
56
529
1.06
0.14
4.2
4.4
%
0.3
0.5
0.58
13
112
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
119
1149
1.04
0.13
2.3
2.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
151
1.13
0.13
1.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
31
335
0.92
0.13
1.4
1.5
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
11
94
1.17
0.13
1.4
1.4
—
19.2
—
0
6
(3034274) Bile acid [Moles/volume] in Serum --fasting
23
209
1.10
0.13
2.4
2.9
umol/l
6.7
7.0
0.04
15
157
(3039443) Prostate specific Ag panel - Serum or Plasma
10
117
0.85
0.13
1.5
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
127
0.86
0.12
3.0
2.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
19
210
0.90
0.12
1.2
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
55
522
1.06
0.12
4.8
4.7
%
0.1
0.1
0.05
14
121
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
158
0.88
0.12
3.0
3.6
%
59.6
55.6
0.70
14
158
(3024928) Oxygen saturation in Venous blood
15
133
1.13
0.12
3.1
6.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
110
1135
0.97
0.11
1.2
1.3
—
—
—
0
0
(1002224) Polysomnography panel
39
368
1.06
0.10
1.0
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
20
183
1.09
0.10
1.0
1.1
u/ml
8.7
7.0
0.11
11
82
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
125
1.12
0.10
1.3
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
44
1.14
0.10
1.6
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
166
0.90
0.10
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
46
1.09
0.09
1.0
1.1
miu/ml
1279.6
1623.9
—
5
46
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
46
1.09
0.09
1.0
1.4
—
—
—
0
0
(4024509)
5
46
1.09
0.09
2.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
48
1.04
0.09
1.0
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
155
0.90
0.09
2.8
3.4
e9/l
4.4
4.0
0.43
14
155
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
97
1.14
0.09
1.5
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
55
1.09
0.09
1.8
1.6
g/l
0.8
1.0
—
6
55
(40761536) Microorganisms panel - Urine sediment
71
686
1.04
0.08
5.5
3.3
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
6
57
1.05
0.08
1.0
1.1
—
45.6
—
0
5
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
57
1.05
0.08
2.3
2.4
ug/l
84.8
17.0
—
6
57
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
58
1.03
0.08
1.0
1.1
—
83.8
—
0
8
(3020961) Endomysium IgA Ab [Titer] in Serum
55
572
0.96
0.08
1.1
1.2
—
143.1
—
0
13
(3028707) Methadone [Presence] in Urine by Screen method
31
328
0.94
0.08
8.8
2.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
65
1.08
0.08
1.4
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
15
137
1.10
0.07
1.1
1.1
iu/ml
3.5
148.2
—
6
43
(3017143) Hepatitis C virus Ab [Presence] in Serum
133
1303
1.02
0.07
1.6
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
153
0.91
0.07
1.1
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
83
0.84
0.07
1.4
1.5
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
8
91
0.88
0.06
1.1
1.1
%
95.4
93.5
—
8
84
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
94
0.85
0.06
1.3
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
46
446
1.03
0.05
3.0
1.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
46
474
0.97
0.04
1.3
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
180
1820
0.99
0.04
2.2
2.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
197
1988
0.99
0.03
2.3
2.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
38
369
1.03
0.03
1.7
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
140
1414
0.99
0.03
1.6
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
118
0.93
0.02
1.5
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
203
1.04
0.01
1.0
1.0
u/ml
4.1
6.5
0.56
11
83
(4035726)
52
527
0.99
0.01
1.2
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
14
136
1.03
0.00
6.8
5.9
umol/l
412.2
390.1
0.22
14
127
(4094501)
15
146
1.03
0.00
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
98
1.02
0.00
1.1
2.6
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
21
207
1.01
0.00
1.2
1.4
pmol/l
80.3
146.9
0.57
21
202
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
44
443
0.99
0.00
1.3
1.3
miu/ml
174.7
245.8
1.11
21
224
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
245
0.98
0.00
1.3
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
26
255
1.02
0.00
1.0
1.1
u/ml
6.2
3.5
—
8
71
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
55
0.91
0.00
1.0
1.6
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
9
95
0.95
0.00
3.9
4.2
u/ml
45.9
311.3
—
9
89
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
64
0.94
0.00
1.2
1.3
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
8
86
0.93
0.00
2.1
1.6
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4281824)
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
72
0.97
0.00
1.3
1.2
—
—
—
0
0
(3032641) Amino acids panel - Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
34.5
—
0
6
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
1.3
—
0.7
—
0
7
(3011648) Oxygen content in Venous blood
5
57
0.88
0.00
3.6
10.3
%
11.5
12.0
—
5
57
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
65.7
—
0
6
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
188.6
—
0
7
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
71
0.99
0.00
1.0
1.0
—
—
—
0
0
(4038314)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
61
0.98
0.00
1.0
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
6
61
0.98
0.00
1.0
1.9
—
19.6
—
0
21
(3042631) Mycobacterium sp identified in Specimen
6
68
0.88
0.00
1.8
3.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
7.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_DEFORMITI_FEET and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_DEFORMITI_FEET | 1.245 [1.01, 1.53] | 0.039 |
| Birth year | 0.997 [0.99, 1.01] | 0.516 |
During the follow-up period (1.1.1998 — 31.12.2019), 139 out of 5121 females with Q17_CONGEN_DEFORMITI_FEET died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_DEFORMITI_FEET | 1.2 [0.98, 1.48] | 0.085 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 158 out of 5999 males with Q17_CONGEN_DEFORMITI_FEET died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_DEFORMITI_FEET.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.132% | 0.187% |
| 5 | 0.679% | 1.352% |
| 10 | 1.731% | 3.274% |
| 15 | 3.539% | 6.665% |
| 20 | 6.656% | 10.99% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_DEFORMITI_FEET – Congenital deformities of feet
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data